1.13
0.00 (0.00%)
| Penutupan Terdahulu | 1.13 |
| Buka | 1.13 |
| Purata Dagangan (3B) | 2,771 |
| Modal Pasaran | 55,154,808 |
| Harga / Pendapatan (P/E TTM) | 28.25 |
| Harga / Jualan (P/S) | 3.53 |
| Harga / Buku (P/B) | 20.43 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 18 Aug 2025 - 22 Aug 2025 |
| Margin Keuntungan | 14.26% |
| Margin Operasi (TTM) | 16.67% |
| EPS Cair (TTM) | 0.040 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 3.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -0.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 179.79% |
| Nisbah Semasa (MRQ) | 1.78 |
| Aliran Tunai Operasi (OCF TTM) | 2.66 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 2.03 M |
| Pulangan Atas Aset (ROA TTM) | 6.75% |
| Pulangan Atas Ekuiti (ROE TTM) | 87.09% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (AU) | Bercampur | Bercampur |
| Diagnostics & Research (Global) | Menaik | Bercampur | |
| Stok | CRYOSITE FPO [CTE] | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.88 |
|
Cryosite Ltd provides an integrated clinical trial logistics service, biological storage and sample management service, including the storage of cord blood stem cells for private use. It supports a diverse portfolio of materials, including Good Manufacturing Practice (GMP) clinical trial products, Australian Register of Therapeutic Goods (ARTG) approved medicines, biologics, Research and Development materials, and medical devices, among others. The group's operating segments are: Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord blood. The majority of its revenue is generated from the Ambient, cold, and frozen segment, which provides storage and distribution of small-molecule drugs and related products requiring ambient, refrigerated, or frozen conditions. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 72.76% |
| % Dimiliki oleh Institusi | 1.56% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |